This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Plantable Health Beheer

Beheer criteriumcontroles 0/4

Plantable Health's CEO is Zayn Kalyan, appointed in Mar 2023, has a tenure of less than a year. directly owns 0.32% of the company’s shares, worth CA$3.00K. The average tenure of the management team and the board of directors is 0.7 years and 0.7 years respectively.

Belangrijke informatie

Zayn Kalyan

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

CEO

Zayn Kalyan

less than a year

Tenure

Mr. Zayn Kalyan serves as Director at Plantable Health Inc. since March 13, 2023 and is its Chief Executive Officer since March 31, 2023. He serves as Partner of Altus Capital Partners. He is Interim Chief...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Zayn Kalyan	CEO & Director	less than a year	geen gegevens	0.32% CA$ 3.0k
Geoffrey Balderson	CFO & Director	less than a year	geen gegevens	geen gegevens
Matt Siegel	Head of Communication & Content	1.8yrs	geen gegevens	geen gegevens
James Wachtel	Chief Growth Officer	1.4yrs	geen gegevens	geen gegevens
Stephanie Sharma	Corporate Secretary	less than a year	geen gegevens	geen gegevens

0.7yrs

Gemiddelde duur

Ervaren management: PLBL's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Zayn Kalyan	CEO & Director	less than a year	geen gegevens	0.32% CA$ 3.0k
Geoffrey Balderson	CFO & Director	less than a year	geen gegevens	geen gegevens
Michael Townsend	Independent Director	less than a year	geen gegevens	8.26% CA$ 78.4k
Kevan Matheson	Director	less than a year	geen gegevens	7.98% CA$ 75.7k
Arndt Roehlig	Independent Director	less than a year	geen gegevens	geen gegevens

0.7yrs

Gemiddelde duur

Ervaren bestuur: PLBL's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.

This company listing is no longer active

Plantable Health Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Plantable Health Inc. Eliminates Position of Elisa Udaskin as Chief Marketing Officer

Less than half of directors are independent

Plantable Health Inc. Appoints James (Jim) Wachtel as Chief Growth Officer

Less than half of directors are independent

Less than half of directors are independent

Plantable Health Inc. Announces Executive Appointments

Recent updates

New major risk - Revenue size

Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.013 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.014 loss in 1Q 2022)

Plantable Health Inc. Eliminates Position of Elisa Udaskin as Chief Marketing Officer

Less than half of directors are independent

Second quarter 2022 earnings released: US$0.013 loss per share (vs US$0.082 loss in 2Q 2021)

Plantable Health Inc. Randomizes Control Trial Opens Enrollment for Prostate Cancer Patients

Plantable Health Inc. Appoints James (Jim) Wachtel as Chief Growth Officer

First quarter 2022 earnings released: US$0.014 loss per share (vs US$0.06 loss in 1Q 2021)

Plantable Health Inc. to Report Q1, 2022 Results on May 13, 2022

Less than half of directors are independent

Full year 2021 earnings released: US$0.12 loss per share (vs US$0.67 loss in FY 2020)

Plantable Health Inc. Provides an Update in Light of International Women's Day on Its Breast Cancer Trial At the Memorial Sloan Kettering Cancer Center

Plantable Health Inc. Provides Update on its Clinical Trials

Less than half of directors are independent

Plantable Health Inc. Announces Executive Appointments

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur